TAGLIAFICO, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 26.142
AS - Asia 13.228
EU - Europa 13.098
SA - Sud America 1.888
AF - Africa 380
OC - Oceania 72
Continente sconosciuto - Info sul continente non disponibili 34
Totale 54.842
Nazione #
US - Stati Uniti d'America 25.674
SG - Singapore 3.909
GB - Regno Unito 3.842
CN - Cina 3.237
IT - Italia 2.703
HK - Hong Kong 1.916
VN - Vietnam 1.590
BR - Brasile 1.420
SE - Svezia 1.372
DE - Germania 1.153
RU - Federazione Russa 649
FI - Finlandia 646
FR - Francia 621
TR - Turchia 461
KR - Corea 425
UA - Ucraina 416
NL - Olanda 403
IN - India 367
ID - Indonesia 267
CA - Canada 255
IE - Irlanda 233
BG - Bulgaria 193
BD - Bangladesh 162
SI - Slovenia 158
AR - Argentina 151
IQ - Iraq 131
JP - Giappone 129
MX - Messico 128
PL - Polonia 113
ZA - Sudafrica 109
ES - Italia 94
PK - Pakistan 85
BE - Belgio 78
EC - Ecuador 77
CO - Colombia 71
CZ - Repubblica Ceca 67
AE - Emirati Arabi Uniti 64
AU - Australia 63
CL - Cile 59
MA - Marocco 57
AT - Austria 55
IR - Iran 54
LT - Lituania 54
MY - Malesia 49
KE - Kenya 48
SA - Arabia Saudita 42
UZ - Uzbekistan 40
EG - Egitto 39
TN - Tunisia 36
CH - Svizzera 34
VE - Venezuela 34
GR - Grecia 28
IL - Israele 28
PH - Filippine 28
TW - Taiwan 28
NP - Nepal 27
PY - Paraguay 26
RO - Romania 26
QA - Qatar 21
AZ - Azerbaigian 19
EU - Europa 19
PE - Perù 19
TH - Thailandia 19
DZ - Algeria 18
JO - Giordania 18
RS - Serbia 17
HU - Ungheria 16
PT - Portogallo 16
NO - Norvegia 15
UY - Uruguay 15
JM - Giamaica 14
KG - Kirghizistan 14
OM - Oman 14
BO - Bolivia 13
DK - Danimarca 13
MD - Moldavia 13
BH - Bahrain 12
AL - Albania 11
KZ - Kazakistan 11
PA - Panama 11
TT - Trinidad e Tobago 11
SN - Senegal 10
CR - Costa Rica 9
ET - Etiopia 9
GE - Georgia 9
NG - Nigeria 9
NZ - Nuova Zelanda 9
SY - Repubblica araba siriana 9
XK - ???statistics.table.value.countryCode.XK??? 9
BY - Bielorussia 8
DO - Repubblica Dominicana 8
HR - Croazia 8
KW - Kuwait 8
MK - Macedonia 8
NI - Nicaragua 7
PS - Palestinian Territory 7
BA - Bosnia-Erzegovina 6
EE - Estonia 6
GH - Ghana 6
LB - Libano 6
Totale 54.724
Città #
Southend 2.721
Ashburn 2.607
Singapore 2.467
Fairfield 2.414
Santa Clara 2.370
Hong Kong 1.858
Chandler 1.515
Woodbridge 1.469
Houston 1.115
San Jose 1.108
Seattle 879
Hefei 828
Ann Arbor 806
Nyköping 775
Wilmington 745
Cambridge 736
Jacksonville 688
Beijing 686
Dearborn 621
London 572
Chicago 509
Ho Chi Minh City 475
Los Angeles 474
Modena 469
Helsinki 443
Seoul 400
Council Bluffs 384
Hanoi 382
The Dalles 355
New York 327
Amsterdam 271
San Diego 268
Izmir 229
Dublin 224
Salt Lake City 207
Milan 203
Jakarta 199
Munich 194
Princeton 191
Sofia 190
Lauterbourg 170
Moscow 168
Shanghai 165
São Paulo 140
Eugene 138
Buffalo 132
Bologna 129
Dallas 125
Fremont 112
Tampa 112
Elk Grove Village 106
Orem 105
Frankfurt am Main 104
Bremen 94
Tokyo 94
Rome 92
Da Nang 77
Falls Church 76
Des Moines 74
Redwood City 71
Warsaw 70
Toronto 69
Brussels 66
Turku 65
Denver 64
Reggio Emilia 62
Johannesburg 60
Montreal 60
Phoenix 60
Columbus 59
Haiphong 59
Parma 58
Nuremberg 56
Chennai 55
Boardman 53
Dong Ket 53
Atlanta 51
Baghdad 50
Guangzhou 50
Sterling 46
Lancaster 45
Brooklyn 44
Mexico City 44
Rio de Janeiro 44
Brno 41
Poplar 41
Biên Hòa 39
Stockholm 39
Manchester 38
Ottawa 38
Brasília 36
San Francisco 36
Nairobi 35
Belo Horizonte 33
Falkenstein 33
Florence 33
Miami 33
Sant'Ilario d'Enza 33
Verona 33
Kent 31
Totale 37.573
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 555
A Next Generation Sequencing amplicon-based strategy to explore Inherited Retinal Degeneration complexity 521
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 500
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 455
Embryonic stem-derived versus somatic neural stem cells: A comparative analysis of their developmental potential and molecular phenotype 448
The barley Frost resistance-H2 locus 441
Transcriptional profiles underlying vulnerability and resilience in rats exposed to an acute unavoidable stress 441
MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation 420
Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells 419
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 419
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 410
NF-YA splice variants have different roles on muscle differentiation 406
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 404
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 398
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Hybrid Posters 397
Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells 393
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 391
Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors 388
A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response 381
Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic microenvironment 380
ERBB2 mutations in hormone receptor positive primary breast cancers samples and in their matched endocrine-resistant recurrences. 378
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 370
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6 364
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 364
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 360
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 360
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 359
Intrinsic phenotypic diversity of embryonic and fetal myoblasts is revealed by genome-wide gene expression analysis on purified cells 358
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 357
Mutations and prognosis in primary myelofibrosis 356
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 356
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 355
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 353
Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis 352
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial 351
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment. 351
Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy 351
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 346
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 344
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis 343
No Identical ‘‘Mesenchymal Stem Cells’’ at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels 343
Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells 342
Microarray analysis of the chronic escape deficit model of depression: Effects of escitalopram treatment in hippocampus 341
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 340
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 340
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group 338
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis 336
From gating to computational flow cytometry: Exploiting artificial intelligence for MRD diagnostics 335
Gene expression in grapevine cultivars in response to BOIS NOIR phytoplasma infection 335
Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation 330
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 329
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis 328
ALTERATA REATTIVITA’ MACROFAGICA IN CORSO DI INFEZIONE MISTA DA VIRUS E FUNGHI:VALUTAZIONI FUNZIONALI, CITOFLUORIMETRICHE E DI ESPRESSIONE GENICA 326
Hereditary pancreatic cancer: A retrospective single-center study of 5143 Italian families with history of BRCA-related malignancies 324
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 323
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 323
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 320
Gene expression profile of vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes 315
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 314
Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression 314
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 311
Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH) 311
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 310
Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: focus on DNA repair genes 302
Regulation of ob gene expression: evidence for epinephrine-induced suppression in human obesity 301
Final results of a phase II randomized trial of neoadjuvant anthracycline-taxane chemotherapy plus lapatinib, trastuzumab, or both in HER2-positive breast cancer (CHER-LOB trial). 298
TGFβ/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts 296
Impact Of Prognostically Detrimental Mutations (ASXL1, EZH2, SRSF2, IDH1/2) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II 296
Brca detection rate in an italian cohort of luminal early-onset and triple-negative breast cancer patients without family history: When biology overcomes genealogy 296
Polarization dictates iron handling by inflammatory and alternatively activated macrophages 295
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 293
Usefulness and limitations of comprehensive characterization of mRNA splicing profiles in the definition of the clinical relevance of BRCA1/2 variants of uncertain significance 293
Gene expression profiling of monocytes displaying herpes simplex virus 1 induced dysregulation of antifungal defences 289
HGM 2010 Programme / Abstract 289
Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation. 288
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation 288
Regulatory Mrna/Microrna Networks in CD34+ Cells From Primary Myelofibrosis 287
Allele specific CRISPR/Cas9 editing of dominant Epidermolysis Bullosa Simplex in human epidermal stem cells 286
Differentiated Neuroprogenitor Cells Incubated with Human or Canine Adenovirus, or Lentiviral Vectors Have Distinct Transcriptome Profiles 286
DIAGNOSI MOLECOLARE DELLE IPERTRIGLICERIDEMIE PRIMITIVE ATTRAVERSO “NGS” (NEXT GENERATION SEQUENCING) 285
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells 283
Identification of new p63 targets in human keratinocytes 282
Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depression 282
Development of an IL-6 antagonist peptide that induces apoptosis in IL-6 dependent 7TD1 cells. 281
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-miR-299-5p in CD34+ progenitor cells commitment 279
Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation 278
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer 273
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 273
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers 271
Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy 270
Transcriptional changes in grapevine in response to Bois Noir infection 267
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 266
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 264
Nfix Regulates Fetal-Specific Transcription in Developing Skeletal Muscle 263
Gene expression profiling in MDS and AML: potential and future avenues 263
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 260
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer 258
FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities 257
All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells 257
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 257
Totale 33.575
Categoria #
all - tutte 205.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 205.656


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021699 0 0 0 0 0 0 0 0 0 0 359 340
2021/20224.037 264 393 391 237 179 251 210 178 401 340 670 523
2022/20234.808 547 595 503 418 516 590 112 432 656 51 194 194
2023/20243.131 117 148 220 259 487 284 387 415 91 124 202 397
2024/202510.174 311 136 226 617 1.859 1.462 841 626 1.192 456 1.150 1.298
2025/202617.975 1.393 841 1.459 2.308 3.455 1.321 2.456 921 1.839 1.886 96 0
Totale 55.246